首页 | 本学科首页   官方微博 | 高级检索  
     

PI3K/mTOR双重抑制剂的研究进展
引用本文:宣 伟,邵 藤,李义平,张三奇. PI3K/mTOR双重抑制剂的研究进展[J]. 医学教育探索, 2012, 27(2): 133-137
作者姓名:宣 伟  邵 藤  李义平  张三奇
作者单位:西安交通大学 医学院 药学系,陕西 西安 710061
摘    要:磷脂酰肌醇3-激酶/哺乳动物雷帕霉素靶蛋白(phosphoinosmde-3-kinase/the mammalian target of rapamycin,PI3K/mTOR)双重抑制剂已经成为抗肿瘤药物研发的热点之一。本文介绍芳基脲类和3-吡啶基杂环类等PI3K/mTOR双重抑制剂的化学结构,根据其结构特点及其与PI3Kγ共结晶模式,剖析了两类抑制剂药效团的基本结构。

关 键 词:PI3K/mTOR双重抑制剂;药效团;抗肿瘤药物

Research progress on PI3K/mTOR dual inhibitors
XUAN Wei,SHAO Teng,LI Yi-ping and ZHANG San-qi. Research progress on PI3K/mTOR dual inhibitors[J]. Researches in Medical Education, 2012, 27(2): 133-137
Authors:XUAN Wei  SHAO Teng  LI Yi-ping  ZHANG San-qi
Affiliation:Department of Pharmacy, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China
Abstract:phosphoinosmde-3-kinase/the mammalian target of rapamycin (PI3K/mTOR) dual inhibitor is emerging as a hotspot in antitumor drugs research. This review introducesthe chemical structures of PI3K/mTOR dual inhibitors which can be sorted into arylureas and 3-pyridinyl heterocycles. The basic pharmacophore structures were suggested according to the structure characteristics of dual inhibitor and tits co-crystal structure with PI3K.
Keywords:phosphoinosmde-3-kinase/the mammalian target of rapamycin (PI3K/mTOR) dual inhibitor   pharmacophore   antitumor drugs
点击此处可从《医学教育探索》浏览原始摘要信息
点击此处可从《医学教育探索》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号